NEJM publishes Takeda's phase 3 data on narcolepsy drug oveporexton

September 9, 2026 8:24 AM

Takeda Pharmaceutical (TSE: 4502 / NYSE: TAK) announced that the New England Journal of Medicine has published results from two ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found